Abstract FKBP65 is an endoplasmic reticulum (ER)-localized chaperone and rotamase, with cargo proteins that include tropoelastin and collagen. In humans, mutations in FKBP65 have recently been shown to cause a form of osteogenesis imperfecta (OI), a brittle bone disease resulting from deficient secretion of mature type I collagen. In this work, we describe the rapid proteolysis of FKBP65 in response to ER stress signals that activate the release of ER Ca 2+ stores. A large-scale screen for stress-induced cellular changes revealed FKBP65 proteins to decrease within 6-12 h of stress activation. Inhibiting IP 3 R-mediated ER Ca 2+ release blocked this response. No other ER-localized chaperone and folding mediators assessed in the study displayed this phenomenon, indicating that this rapid proteolysis of folding mediator is distinctive. Imaging and cellular fractionation confirmed the localization of FKBP65 (72 kDa glycoprotein) to the ER of untreated cells, a rapid decrease in protein levels following ER stress, and the corresponding appearance of a 30-kDa fragment in the cytosol. Inhibition of the proteasome during ER stress revealed an accumulation of FKBP65 in the cytosol, consistent with retrotranslocation and a proteasome-based proteolysis. To assess the role of Ca 2+ -binding EF-hand domains in FKBP65 stability, a recombinant FKBP65-GFP construct was engineered to ablate Ca 2+ binding at each of two EF-hand domains. Cells transfected with the wild-type construct displayed ER localization of the FKBP65-GFP protein and a proteasome-dependent proteolysis in response to ER stress. Recombinant FKBP65-GFP carrying a defect in the EF1 Ca 2+ -binding domain displayed diminished protein in the ER when compared to wild-type FKBP65-GFP. Proteasome inhibition restored mutant protein to levels similar to that of the wild-type FKBP65-GFP. A similar mutation in EF2 did not confer FKBP65 proteolysis. This work supports a model in which stress-induced changes in ER Ca 2+ stores induce the rapid proteolysis of FKBP65, a chaperone and folding mediator of collagen and tropoelastin. The destruction of this protein may identify a cellular strategy for replacement of protein folding machinery following ER stress. The implications for stress-induced changes in the handling of aggregateprone proteins in the ER-Golgi secretory pathway are discussed.
Introduction
The endoplasmic reticulum (ER) is a key site of protein production, glycosylation, and transport in all eukaryotic cells. The ER has the ability to assess success/failure of protein processing and regulate signaling pathways that affect translation initiation, gene expression, organelle size, and even apoptotic pathways (Ron and Walter 2007) . Studies have revealed ER stress to activate the unfolded protein response (UPR), resulting in phosphorylation of eIF2α in the cytosol, arresting most translation, and the production of transcription factors that elevate adaptive gene expression in the nucleus (Rutkowski and Kaufman 2004) . Sustained ER stress can activate apoptosis via release of ER Ca 2+ stores, activation of intrinsic (mitochondrial) apoptosis, and/or via activation of ER-associated caspases. The clearance of accumulating misfolded proteins from the ER occurs primarily via retrotranslocation to the cytosol and proteasome-mediated destruction, which is the ER-associated destruction (ERAD) pathway. The complexities of ER function and signaling lend susceptibility of this organelle to the inappropriate activation of apoptosis in indispensable cell types. Stress signaling from the ER has been linked to human disease, including disease resulting from ER-induced activation of neuronal apoptosis (Bandopadhyay and de Belleroche 2010; Inagi 2010; Kaser et al. 2008) .
Protein folding within the ER/Golgi apparatus involves addition/trimming of carbohydrates, interaction with chaperone binding partners that both aid in folding and inhibit export of incompletely processed proteins from the ER. The ER lumen contains several types of protein-folding mediators, including HSP70-family chaperones (GRP78/BiP), HSP90-family chaperones (GRP94), and disulphide isomerases (PDI, ERp72). Folding mediators in the ER include peptidyl-prolyl cis-trans isomerase (PPIase) or "rotamase" enzymes (Kang et al. 2008) . PPIases catalyze the interconversion of cis/trans isomers of peptidyl-prolyl bonds in proteins containing proline, an activity displayed by both cyclophilin, parvulin, and FK506-binding (FKBP) protein superfamilies (Gothel and Marahiel 1999) . During folding of nascent proteins, this conversion is the rate-limiting step in the folding process (99.9% trans in denatured protein,~50% trans in folded protein). These enzymes often function in complexes with chaperones or other folding mediators. Beyond playing a role in the appropriate folding of nascent proteins, some PPIase proteins play a role in signal transduction by facilitating protein conversion to active protein conformations. The PIN1 PPIase facilitates isomerization of only phosphorlyated-Ser/Thr-Pro motifs on substrate proteins, regulating a wide array of cellular functions including gene expression, cell division, and stress response (Butterfield et al. 2006; Lu and Zhou 2007; Rudrabhatla and Pant 2010; Takahashi et al. 2007 ). The FKBP52/HSP90 complex binds to cytoplasmic glucocorticoid receptors, enhancing receptor affinity for steroid ligand and facilitating interaction between the bound receptor and dynein during receptor translocation to the nucleus (Davies and Sanchez 2005) . In neurodegenerative diseases displaying a toxic accumulation of Tau protein, FKBP51/HSP90 complexes bind microtubuleassociated Tau protein, elevating the association of Tau proteins with microtubules and enhancing the formation of toxic Tau aggregates (Jinwal et al. 2010) .
FKBPs are PPIase enzymes that bind to FK506 and rapamycin, but not to cyclosporine. These enzymes have been identified in all living organisms from bacteria to metazoans (Kang et al. 2008) . Some FKBP proteins display chaperone activity in addition to PPIase activity, binding to exposed hydrophobic domains of misfolded proteins and preventing their spontaneous aggregation (Ishikawa et al. 2008; Kang et al. 2008 ). There are five FKBP proteins known to be localized within the ER: FKBP13, FKBP22, FKBP23, FKBP60, and FKBP65. These FKBP proteins are differentially expressed depending upon cell type. Five of these proteins contain two EF-hand Ca 2+ -binding domains (only FKBP13 lacks these domains). FKBP22 and FKBP23 have been shown to bind GRP78/BiP chaperone in a Ca 2+ -dependent manner, potentially playing a role in regulating chaperone activity (Tremmel and Tropschug 2007; Wang et al. 2007 ). FKBP65 (encoded by gene FKBP10) is the largest of the FK506-binding proteins, containing four PPIase domains, two C-terminal EF-hand domains, and a C-terminal HEEL domain for ER localization. FKBP65 activity mediates the appropriate folding of collagen and associates with tropoelastin (the soluble precursor to elastin); both are proline-rich proteins that contribute to the extracellular matrix of tissue (Alanay et al. 2010; Davis et al. 1998; Ishikawa et al. 2008; Patterson et al. 2000 ). An analysis of expression patterns of FKBP65 in lung tissue revealed active expression to be coordinated with tropoelastin production during lung development and re-growth following injury (Patterson et al. 2005) . The conformational changes associated with tropoelastin maturation and formation of elastin fibers are not well understood. In vitro modeling of elastin fiber formation has revealed the coacervation (formation of large droplets) of tropoelastin to precede elastin fiber formation, potentially mimicking the in vivo process. Recombinant FKBP65 initiates coacervation of tropoelastin independent of PPIase activity, suggesting a separate chaperone capability for this enzyme (Cheung et al. 2010) . In human populations, mutation of the FKBP65 PPIase domain I or truncation of the protein results in osteogenesis imperfecta (OI), a heritable disease displaying abnormal type I collagen processing, abnormal collagen secretion, and ultimately severe bone defects (Alanay et al. 2010) .
FKBP65 has two Ca 2+ -binding EF-hand domains and is localized within the ER lumen, a key site of cellular Ca 2+ storage. In this manuscript, we examine FKBP65 localization and stability within the ER following activation of ER stresses associated with the release of ER Ca 2+ stores. In addition, we examine the impact of EF-hand Ca 2+ -binding domain mutation upon the stability of FKBP65. The revealed stress-induced proteolysis of an ER rotamase may reveal a cellular strategy for rapidly replacing select protein-folding enzymes, or regulating the processing of aggregation-prone cargo within the secretory pathway.
Materials and methods
Cell lines and cell culture BHK21 hamster kidney, RFL6 rat lung fibroblast, and SH-SY5Y human neuroblastoma cells were purchased from American Type Culture Collection (ATCC). Dr. Claudio Basilico (New York University, Medical School) provided the tsBN7 cell line, derived from BHK21 cells (Nakashima et al. 1993 ). BHK21 and tsBN7 cells were cultured in Dulbecco's modified Eagle's medium (4,500 mg/l glucose, 110 mg/l pyruvate, and 4 mM L-glutamine) supplemented with 10% heat-inactivated fetal bovine serum, non-essential amino acids, and antibiotics. RFL6 were cultured in Ham's F-12 with 20% FBS, non-essential amino acids, and antibiotics. SH-SY5Y cells were cultured in a 1:1 mixture of F-12 and DMEM media as described by ATCC. The tsBN7 cells were maintained at 32.5°C and temperatureshifted (TS) experiments performed at 39.5°C. All other cells were maintained at 37°C. Transfection-based experiments were performed using Lipofectamine 2000, Invitrogen (San Diego, CA, USA).
ER stress-inducing toxins Brefeldin A, tunicamycin (TUN), and thapsigargin, as well as cycloheximide and staurosporine, were purchased from Calbiochem (San Diego, CA, USA). MG132, Proteasome Inhibitor-II, z-VAD-fmk, Calpain Inhibitor-III and -IV, and Calpeptin were purchased from Calbiochem (San Diego, CA, USA).
Clasto-lactacystin-β-lactone (lactacystin) was purchased from Cayman Chemical Company (Ann Arbor, MI, USA), and 2-aminoethoxyphenylborate (2-APB) was purchased from Sigma (St. Louis, MO, USA).
Antibodies for GRP94, DFF45, MSH3, FKBP65 (C-terminal), and FKBP12 were purchased from BD Pharmingen (San Diego, CA, USA). Antibodies for β-actin, calreticulin, nuclear lamin, ERp72, and ERp57 were purchased from Cellular Signaling Technology (Danvers, MA, USA). As mutation of the EF-hand domains eliminates C-terminal binding of FKBP65 by the BD Pharmingen monoclonal antibody, a rabbit polyclonal anti-FKBP65 antibody was used for experiments shown in Figs. 6 and 7 (Proteintech Group Inc., Chicago, IL, USA).
Becton Dickenson Powerblot™ western array
To perform an assessment of proteomic changes in tsBN7 cells during ER stress, whole cell lysates were prepared from cells treated with either TUN (1 μM) or temperature shift conditions (39.5°C) for 24 h. Lysates were isolated via cell lysis in an SDS-lysis solution (62.5 mM Tris 6.8, 2% SDS, 7% glycerol) preheated to 95°C. Lysates from two identical experiments were sent to Becton Dickenson/ Pharmingen (San Diego, CA, USA) for analysis using their Powerblot™ services. Control, TS-treated, and TUNtreated samples were comparatively analyzed for 997 different protein targets using a quantitative analysis of luminescent signal. All blots were normalized to the sum intensity of all valid spots on a blot. Normalized data was finally expressed as a ratio to convey a fold change of protein expression in experimental conditions relative to control. Results for individual proteins were replicated via immunoblot, confirming the majority of results identified by the Powerblot™ analysis.
Quantitative reverse-transcription/polymerase chain reaction (Q-RT/PCR) To assess stress-induced changes in gene expression, Q-RT/ PCR was employed using Taqman primer pairs and PCR components according to standard protocols (Applied Biosystems; Foster City, CA, USA). PCR amplification of reverse-transcribed cDNA was quantitatively assessed relative to a set of template standards of known concentration. For each experimental set of RNA samples, the expressions of FKBP10 (encodes FKBP65), GRP78, and GAPDH were experimentally determined.
Protein isolation/immunoblots and immunocytochemistry
Cells were seeded in tissue culture plates 24 h prior to the beginning of an experiment. To isolate proteins for immunoblot analysis, cells were washed gently with Dulbecco's phosphate-buffered saline (DPBS), and then lysed using a heated 2% SDS-lysis solution. Protein concentrations were determined using a bicinchoninic acid assay (BCA Assay; Pierce, Rockford, IL, USA), and 100 μg of total protein was used for SDS-PAGE analysis. After transfer to nitrocellulose, equal loading was confirmed by visual inspection following staining using a solution of Ponceau S (0.1%) in 5% acetic acid. Standard protocols were used for immunoblot analysis, and signals were detected using a horseradish peroxidase-conjugated secondary antibody with a luminol-based substrate (Pierce, Rockford, IL, USA). Cellular fractionation experiments involved similar immunoblot analysis techniques though the initial fractionation of cells was performed using manufacturer-provided reagents and protocols (Cell Compartments kit; Qiagen, Santa Clarita, CA, USA).
For experiments involving immunocytochemistry, cells were seeded onto ethanol-cleaned glass coverslips to a density of 50-70%. Following experimental treatment, cells were fixed in 4% paraformadehyde/PBS (pH 7.4) for 20 min, aspirated, and gently washed with PBS. Fixed cells were permeabilized/blocked for 1 h (at 4°C) in a PBS solution containing 0.2% Triton X-100 and 5% bovine serum albumin (BSA) solution. Primary antibody was diluted to a final concentration of 2 μg/ml in a PBS/0.2% Triton X-100/2% BSA solution. The primary antibody was incubated on the coverslips overnight (~12-16 h) at 4°C. Coverslips were washed and then covered with a PBS-based solution containing conjugated secondary antibody (1 μg/ml) and 4′-6-diamino-2-phenylindole (DAPI, 1 μg/ml). After a 1-h incubation, coverslips were washed and then mounted onto slides using Fluoromount G with 0.1% p-phenylenediamine. For cells expressing fluorescent proteins (GFP and RFP), the coverslips were fixed and stained with DAPI as mounted and described above.
Calpain and proteasome enzymatic assays
To assay for calpain activity cell lysates, a flourometric assay was used (BioVision; Mountain View, CA, USA). Cell lysates were generated according to the product guide, assayed for protein concentration, combined with assay buffer containing calpain substrate (Ac-LLY-AFC), and incubated at 37°C for 1 h. Fluorescence of each sample was measured with excitation at 400 nm and emission at 505 nm. Relative fluorescence was recorded for each milligram of protein in sample lysate. Negative controls included 5 μM z-LLY-fmk, a potent inhibitor of calpain activity. In vitro proteasome activity was measured using the Proteasome-Glo Chymotrypsin-like cell-based assay (Promega; Madison, WI, USA). Cells were seeded in a 96-well black-walled, clear bottom, fluorescence tissue culture plate at a density of 10,000 cells/well. The luminogenic substrate used for the proteasome activity was Suc-LLVY-aminoluciferin. Proteasome inhibitor (MG132, 5 μM) was added to identify any signal generated independently of proteasome activity. Analysis of variance (ANOVA) with a Tukey all pairs post hoc statistical test was performed to determine any statistically significant changes in calpain or proteasome activity following treatment.
Site-directed mutagenesis A full-length, FKBP10 cDNA clone (in pCMV6-AC), encoding the Mus musculus FKBP65 protein, was purchased from Origene Technologies (Rockville, MD, USA). All experiments presented in this manuscript include FKBP65 with a C-terminal fusion to monomeric green fluorescent protein (GFP). The construct was sequenced to confirm an intact open reading frame before beginning the site-directed mutagenesis. Primer pairs designed to alter four sequences in the construct were synthesized by Sigma-Genosys (St. Louis, MO, USA). Mutagenesis included the addition of a C-terminal HEEL domain to the absolute C-terminus of GFP, and insertion of a GSGS flexible linker between FKBP65 and the N-terminus of GFP. The construct containing the HEEL and GSGS modifications became our wild-type (WT) construct. Mutagenesis of the EF-hand Ca 2+ -binding domains included substituting glutamate residues for lysine residues, which removes Ca 2+ -binding capability (Kesvatera et al. 2001) . For the EF1 domain (amino acids 509-52), glutamate codons 519 and 520 were mutated to lysine codons with a single nucleotide substitution at each codon to create the mEF1 mutation. For the EF2 domain (amino acids 554-565), glutamate codons at amino acids 564 and 656 were mutated to lysine codons with a single nucleotide substitution at each codon to create the mEF2 mutation. The double mutant plasmid was created by mutagenizing the mEF1 construct, creating the mEF1/ mEF2 construct. Mutagenesis reactions were performed using the Stratagene Quikchange Lightning site-directed mutagenesis kit according to the manufacturer's instructions (La Jolla, CA, USA). Amplified products were enriched for mutation-bearing products using DpnI digestion before transformation of Escherichia coli. Plasmid DNA from ten colonies (per mutagenesis) was clonally isolated for each mutagenesis and sequenced (Retrogen; San Diego, CA, USA). The final constructs (wt, mEF1, mEF2, and mEF1/mEF2) were sequenced throughout the entire open-reading frame to confirm the integrity of the plasmid sequence.
Results

ER stress induces a rapid decrease in FKBP65 protein
To assess changes in protein stability and expression following ER stress, protein lysates were isolated from tsBN7 cells experiencing ER stress and analyzed via an antibody array (Powerblot™, Becton Dickenson). The temperature-sensitive tsBN7 cells carry a single amino acid substitution mutation in DAD1, a subunit of the oligosaccharyltransferase (OST) enzyme complex that mediates N-linked glycosylation in the ER (Nakashima et al. 1993) . At the restrictive temperature, these cells display defective N-linked glycosylation, ER stress signaling, and ultimately activate intrinsic apoptosis (Niederer et al. 2005) . ER stress was induced in tsBN7 cells via a 24-h exposure to the restrictive temperature (TS, 39.5°C) or TUN (1 μM, 32.5°C). Both of these treatments activate ER stress by inhibiting N-linked glycosylation and are similar, but not identical stressors (Niederer et al. 2005 ). An examination of the immunoblot arrays yielded both expected changes in gene expression following ER stress, and some unexpected changes (Supplements 1 and 2). Figure 1a includes examples of detected changes that include an increase in GRP78/Bip and HSP70 chaperones, increased β-catenin, and increased p27/KIP1, a cyclin-dependent kinase inhibitor. These changes are consistent with stressed cells that arrest cell division and activate the expression of adaptive chaperone proteins. In addition, markers for cellular apoptosis were observed, including decreased levels of full-length DFF45, a nuclease that is activated by truncation in apoptotic cells, and increased MSH3 (an inducible DNA repair enzyme). The dramatic decrease of an ER-localized rotamase (FKBP65) was surprising as ER stress signaling often induces protein-folding mediators via the UPR signaling pathway.
Immunoblot analysis was performed to comparatively assess the response of ER-localized protein-folding mediators during stress treatment (Fig. 1b) . TS treatment was compared to three additional ER stress-inducing agents (TUN, thapsigargin (THAP), and Brefeldin A (BFA)). Also evaluated were staurosporine (STS), a protein kinase inhibitor known to activate stress/apoptosis independent of ER signaling, and cycloheximide (CHX), an inhibitor of translation initiation. TS, TUN, and THAP each induced a rapid decrease in FKBP65 levels. Of the ER-localized folding mediators assessed, only FKBP65 exhibited a rapid destruction following ER stress. Attempts to assess FKBP13 or FKBP23 with commercially available antibodies yielded no detectable levels of these proteins in tsBN7 cells. We note that BFA, which inhibits vesicular transport between the ER and the Golgi apparatus and activates ER stress signaling pathway, did not induce the loss of FKBP65 in tsBN7 fibroblast cells. CHX did not cause a decrease in FKBP65 levels, revealing that the loss of FKBP65 was not due to diminished translation during ER stress. Activation of apoptosis via STS did not cause the destabilization of FKBP65, consistent with FKBP65 proteolysis being specific to ER stress-induced signaling.
When FKBP65 levels were evaluated over a 36-h time course of ER stress (TS or TUN), ER stress was shown to induce the rapid loss of the normal 72-kDa form of the protein, though late time points revealed the weak re-accumulation of a smaller 58-kDa form of the protein (Fig. 1c) . This molecular weight matches the molecular weight of non-glycosylated FKBP65 (Coss et al. 1995) . We interpret this partial re-accumulation to indicate that the ER stress-induced destruction of FKBP65 is most active within the first 24 h of ER stress exposure; this diminished proteolysis may coincide with the signaling transition from UPR signaling to pro-apoptotic signaling. An analysis of FKBP65 in a rat lung fibroblast cell line (RFL6) revealed a similar time course of FKBP65 loss in response to TUNinduced ER stress.
Pro-apoptotic stress signaling within the ER is known to activate Ca 2+ release into the cytosol, stimulating Ca 2+ -dependent cytosolic proteases (calpains) and activating cysteine-dependent aspartate-directed proteases (caspases). Inhibition of N-linked glycosylation has been shown to activate the release of ER Ca 2+ stores via the inositol triphosphate receptor (ITPR) and activate apoptosis (Deniaud et al. 2008; Li et al. 2009 ). Inhibition of ER Ca 2+ release or calpain activity was sufficient to significantly diminish apoptosis activation in TS-treated tsBN7 cells (Fig. 1d) , revealing Ca 2+ and calpain activity to play an important role in apoptotic progression. Apoptosis was quantified by counting condensed and fragmented nuclei stained with DAPI. Non-stressed cells display apoptotic nuclei 4% of the population, while sustained ER stress (36 h) generates apoptotic nuclei in 20% of observed cells. Inhibition of ITPR-based Ca 2+ release (2-APB) or calpain activity (calpeptin (CAL)) significantly reduced the activation of apoptosis to near the levels of nonstressed cells (5-9%). Inhibition of ER Ca 2+ release or calpain activity also diminished, but did not completely eliminate, FKBP65 proteolysis in TS-treated cells (Fig. 1e) . A broad-spectrum inhibitor (z-VAD) of cellular caspase-type proteases had no affect upon FKBP65 proteolysis. Calpains are well-known activators of cytosolic signaling downstream of ER stress activation, inducing caspase activities linked to feedback reinforcement of ER stress signals. Thus, calpains could potentially play a direct role in proteolysis of FKBP65, or they may play a role in activating the stress response that generates FKBP65 proteolysis.
ER stress does not inhibit FKBP65 transcription
In order to assess the transcription of FKBP65 in cells experiencing ER stress, we used a human cell line (SH-SY5Y) to enable the use of commercially available quantitative RT/PCR primers. This neuroblastoma cell line activates robust ER stress/apoptosis in response to BFA exposure, while a much slower and moderate activation of ER stress signaling was observed following TUN treatment. This is consistent with previous work on ER stress and neuronal cell types (Brewster et al. 2006) . Similar to what was observed in tsBN7 cells experiencing deficient N-linked glycosylation or depletion of ER Ca 2+ stores, the BFA exposed neurons displayed a rapid decrease in FKBP65 protein levels (Fig. 2a) . Quantitative RT/PCR revealed GRP78/Bip expression to increase over eightfold in the first 6 h of ER stress, while FKBP65 expression remained relatively constant throughout the 24-h exposure (Fig. 2b) . This result is consistent with a model that identifies enhanced proteolysis rather than inhibition of transcription as responsible for diminished FKBP65 levels.
FKBP65 localization to the ER is diminished following ER stress
To assess the sub-cellular localization of FKBP65, tsBN7 fibroblasts were transfected with a plasmid encoding a red fluorescent protein containing a C-terminal KDEL motif, which signals ER-retention (pDsRed2-ER, Clontech). Transfected cells were then evaluated for either FKBP65 or calreticulin (an ER-resident protein) using primary antibodies and an Alexa488-tagged secondary antibody (Fig. 3) . Both FKBP65 and calreticulin displayed a co-localization with the ER in non-stressed cells. ER stress induced an overall decrease in FKBP65 staining intensity, and the appearance of antibody-reactive punctate spots that were not apparent in non-stressed cells. Calreticulin localization or staining intensity was not visibly altered in response to ER stress. ER stress can induce dramatic structural changes in the ER that include expansion of the ER. The localization of FKBP65 to punctate spots preceded any obvious changes in general ER structure or size. To further assess the localization of FKBP65 during ER stress-induced proteolysis, cell fractions were generated using differential organelle lysis and centrifugation (Fig. 4) . The quality of fractions cytosolic/ membrane/nuclear was assessed by immunoblotting fractions for m-calpain (cytosolic), calreticulin (ER/membrane), and lamin (nuclear). FKBP65 was localized within the membrane fractions of non-stressed cells, consistent with ER localization. Following ER stress, FKBP65 levels diminished within the ER, and a weakly detectable 30-kDa band intensified within the cytosolic fractions.
FKBP65 proteolysis is dependent upon proteasome activity
Fluorescent and luminescent peptide-based assays were used to assess the activity of calpain proteases and the proteasome over the time interval that corresponds with FKBP65 proteolysis. Analysis revealed both calpain and proteasome activities to be present in non-stressed cells, with inclusion of an inhibitor arresting 80% or more of detected activity. Activation of ER stress did not significantly induce either of these classes of protease at acute time points (Fig. 5a, b) . Cells experiencing ER stress were exposed to inhibitors of cellular calpains or the proteasome and total cellular proteins isolated for analysis. Three distinct calpain inhibitors conferred partial inhibition of ER stress-induced proteolysis of FKBP65 (similar to Fig. 1e ), while inhibitors of the proteasome display nearly complete inhibition of FKBP65 destruction (Fig. 5c ). MG132 (z-Leu-Leu-Leu-CHO) and Proteasome Inhibitor II (z-Leu-Leu-Phe-CHO) are peptide aldehyde-based inhibitors that have some capacity to inhibit calpains when used at high concentrations (Lee and Goldberg 1998) . Clastolactacystin β-lactone (LTC), a potent proteasome inhibitor that does not inhibit calpain proteases, completely inhibited FKBP65 proteolysis during ER stress. Cellular fractions were generated from cells experiencing ER stress in the presence or absence of calpain (CI-III) or proteasome (LCT) inhibitors. In non-stressed cells, FKBP65 was localized to the membrane fraction, consistent with ER localization (Fig. 5d) . Similar to what was observed previously, LCT inhibited FKBP65 proteolysis, while CI-III offered modest protection. In samples isolated from cells experiencing ER stress in the presence of the LCT proteasome inhibitor (or other protease inhibitors), we observed no accumulation of proteolytic products, which would be anticipated if calpain were playing a direct role in Fig. 1 Endoplasmic reticulum stress induces FKBP65 proteolysis. a Representative immunoblot results from Powerblot™ analysis of lysates from tsBN7 cells. Cells were exposed to 39.5°C (TS) or tunicamycin (TUN, 1 μM) for 24 h. b Immunoblot analysis of select ER-localized folding mediators following a 6-h exposure to ER stressor; staurosporine (STS, 1 μM), an ER-independent apoptosis activator; or cyclohexmide (CHX, 10 μM). c A time course of FKBP65 proteolysis following activation of ER stress with either TS or TUN treatment. Note the appearance of underglycosylated FKBP65 after 18 h of stress exposure. d Pro-apoptotic ER stress signaling can be inhibited by blocking ER Ca 2+ release (2-APB, 50 μM) or cellular calpain proteases (calpeptin, 100 μM). Significant differences between TS-treated cells and TS-treated cells with inhibitors were observed at 36 and 48 h (ANOVA statistical test, p<0.05). e Inhibition of calpains or ER Ca 2+ release is sufficient to partially block FKBP65 proteolysis following ER stress b FKBP65 proteolysis. ER stress in the presence of LCT revealed FKBP65 retrotranslocation and accumulation within the cytosol. Densitometry revealed that 10-20% of total FKBP65 could be detected in the cytosol of stressed cells. We note that accumulated cytosolic FKBP65 appeared to be 72 kDa in size and did not show signs of cytosolic deglycosylation, which is sometimes associated with retrotranslocated proteins. No cytosolic accumulation of FKBP65 was observed in cells stressed in the absence of inhibitor or treated with CI-III. These results are consistent with FKBP65 being retrotranslocated to the cytosol in response to ER stress and proteolytically degraded by the proteasome.
Mutagenesis of EF-hand domains
ER stress has been shown to activate diverse signaling pathways via transmembrane proteins located in the ER Fig. 2 ER stress does not inhibit FKBP65 expression. a In human SH-SY5Y cells, ER stress was induced using Brefeldin A (20 μM), activating a rapid depletion of FKBP65, similar to that seen in fibroblast cell lines. b Quantitative reverse transcription followed by polymerase chain reaction (RT/PCR) was used to examine the effect of ER stress upon expression of FKBP65 and GRP78. The prevalence of each transcript was determined by normalizing PCR amplification signal relative to a known standard for each gene. Normalized to t=0, ER stress induces an eight-fold increase in GRP78 expression and a moderate increase in FKBP65 expression Fig. 3 ER stress diminishes FKBP65 co-localization with the ER. tsBN7 fibroblasts were transfected with pER-RFP (Invitrogen) to label the endoplasmic reticulum with RFP. Immunologic detection of FKBP65 or calreticulin involved a primary antibody detected with an Alexa 488-conjugated secondary antibody (Molecular Probes; Eugene, OR, USA). A 12-h TS treatment was used to induce ER stress in these tsBN7 fibroblasts. FKBP65, but not calreticulin, displayed diminished signal intensity and ER localization following TS treatment membrane and through the enhanced release of Ca 2+ from ER luminal stores. As FKBP65 carries two C-terminal EF-hand Ca 2+ -binding domains (Fig. 6a) , we hypothesized that stress-induced changes in [Ca 2+ ] ER might impact these domains to stimulate retrotranslocation and proteolysis of this rotamase protein. In other proteins, these domains have been shown to mediate Ca 2+ binding, structural regulation of the protein, and the regulation of protein-protein interactions (Grabarek 2006; Lewit-Bentley and Rety 2000) . The Ca 2+ -binding pocket of an EF-hand domain is always bordered by acidic amino acids (aspartate, A and glutamate, E) with side chain carboxylates that are negatively charged at neutral pH and can bind Ca 2+ via charge interactions. The Ca 2+ -binding pocket of each FKBP65 EF-hand domain was mutagenized through the substitution of two positively charged lysine amino acids for two glutamate amino acids (Fig. 6b) . In the characterization of EF-hand-containing proteins, this type of substitution has been shown to be effective in eliminating Ca 2+ binding (Kesvatera et al. 2001) . A full-length cDNA of mouse FKBP65 was fused to monomeric GFP with the intervening insertion of a flexible linker domain (GSGS). At the C-terminus of the construct, a HEEL domain was inserted to ensure ER retention of the fusion protein. To assess the sub-cellular localization of this construct, tsBN7 cells were transfected with a plasmid encoding an ER-specific red fluorescent protein (ER-RFP), and either rFKBP65-GFP or GFP (Fig. 6c) . Using fluorescent microscopy to analyze transfected cells, the FKBP65-GFP fusion protein was confirmed to co-localize with the ER-RFP, while the GFP did not show co-localization. To further assess localization of rFKBP65-GFP, cells were transfected with each construct (wt, mEF1, mEF2, or the double mutant (mEF1/mEF2)). Transfected cells were lysed and separated into fractions using differential centrifugation as previously described. The 97-kDa recombinant protein (~72 kDa FKBP65+~27 kDa GFP) displayed a clear association with the membrane fraction, which contains the ER and mitochondria. Despite transfection experiments being equal with regard to the number of transfected cells and the mass of DNA added during transfection, the mEF1-containing forms of the recombinant protein were observed at severely diminished levels relative to the wild-type protein. The proteins that were detected, though lower in concentration than the wild-type fusion protein, were localized within the membrane fraction.
To determine if the rFKBP65-GFP protein was subject to proteasome degradation in response to ER stress, tsBN7 cells were transfected, and ER stress was induced in the presence or absence of MG132. Similar to the native FKBP65 protein, the recombinant protein decreased following ER stress activation though not as rapidly as the native protein (Fig. 7a) . Inhibition of the proteasome was sufficient to arrest this proteolytic destruction of both the native and recombinant FKBP65. We note that the recombinant protein is detected via immunoblot primarily as the 97-kDa band, but that a smaller protein (87-90 kDa) of lower intensity is also recognized by the antibody. This~90-kDa band initially increases in intensity in response to stress, potentially identifying a uniquely glycosylated or otherwise modified form of the recombinant protein.
The EF-hand-deficient forms of rFKBP65 displayed lower levels of protein accumulation compared with the wild-type recombinant protein. Mutation of EF-1 was shown to have a more dramatic affect upon stability than mutation of the second (C-terminal) EF-hand domain. This instability following a loss of Ca 2+ binding by an EF-hand domain was consistent with our hypothesis that Ca 2+ -binding by FKBP65 served to facilitate its stability within the ER lumen. If this diminished accumulation of mutant forms of recombinant FKBP65 were due to a proteasome-dependent proteolysis, proteasome inhibition should increase the level of these proteins within the cell to levels comparable to the wild-type rFKBP65. As is shown in Fig. 7b , addition of MG132 restored each EFhand mutant to levels similar to the wild-type rFKBP65 protein. In support of our hypothesis that the EF-hand domains play a significant role in the stability of FKBP65 within the ER, the Ca 2+ -binding pocket mutant forms of Fig. 4 ER stress induces a decrease of FKBP65 localization to membrane fractions and evidence of a cytosolic cleavage product. Subcellular fractionation was performed using cell lysates from tsBN7 cells exposed to TS for 0, 6, or 12 h. Fractions generated were cytosolic, membrane (ER, mitochondria), and nuclear fractions. The integrity of each fraction was determined by examining markers for each cellular compartment (cytosol, calpain; ER, calreticulin; nucleus, lamin) . Following ER stress, FKBP65 within the ER diminishes in intensity, while a 30-kDa FKBP65 antibody-reactive protein increases in intensity this recombinant protein display clear differences in ER stability.
Discussion
Proteostasis (protein folding homeostasis) is a critical characteristic of cellular health, ensuring the appropriate production of functionally folded proteins balanced with the proteolytic destruction of terminally misfolded proteins. Peptidyl-prolyl cis/trans isomerase (PPIase or rotamase) enzymes located within the ER lumen are not well characterized but have been associated with the appropriate folding of some ER cargo proteins. FKBP65 is the largest known rotamase enzyme, with four PPIase domains (Coss et al. 1995) , whose expression serves as a marker for cancerous transformation of colorectal cells, and also for the repair of lung tissue following injury (Olesen et al. 2005; Patterson et al. 2005) . Humans with deleterious mutations in FKBP65 display severe defects in collagen deposition and bone development, as revealed in the heritable disease OI. Cultured cells from these An assay of cellular calpain and proteasome activities following ER stress activation in tsBN7 fibroblasts. In each case, the cleavage of fluorogenic substrates for protease activity was quantitatively measured using 96-well plate assays. Both activities are present in these cells, but ER stress does not significantly alter activity at acute time points. Statistical significance was determined using ANOVA with a Tukey's all pairs post hoc test (p<0.05). c Assessment of ER stress-induced proteolysis of FKBP65 in the presence of different membrane permeable calpain or proteasome inhibitors (6-h time point). Proteasome inhibitors (MG132, 5 μM; lactacystin (LCT), 5 μM; Proteasome Inhib. II, 5 μM) were highly effective at inhibiting FKBP65 proteolysis, while calpain inhibitors partially inhibited this phenomenon (calpeptin (CAL), 100 μM; Calpain Inhib. III/IV, 10 μM). d Subcellular fractionation was performed using cell lysates from tsBN7 cells exposed to TS for 6 or 9 h in the presence or absence of calpain inhibitor (CI-III, 10 μM) or proteasome inhibitor (LCT, 5 μM). The quality of cellular fractions was assessed using m-calpain as a marker of the cytosol and calreticulin as an ER-specific marker for the membrane fraction. To enable visualization of the 30-kDa band, the cytosolic FKBP65 panel was exposed 5× longer than the membrane panel in 5D. All other paired panels were exposed to film for identical time periods. TS treatment generated an accumulation of cytosolic FBKP10 when the proteasome was inhibited, but not when calpain was inhibited individuals display normal expression of collagen, though the collagen is abnormally distributed in cellular aggregates, presumably due to a missing processing step involving FKBP65, and is exported from the cell at deficient levels relative to wild-type cells (Alanay et al. 2010) . In this manuscript, we have shown that the ER-localized FKBP65 rotamase is proteolytically destroyed in response to ER stress activated by thapsigargin, or with the inhibition of N-linked glycosylation, both which are known to deplete ER Ca 2+ stores (Deniaud et al. 2008 ). Inhibition of IP 3 Rbased ER Ca 2+ release was sufficient to protect against FKBP65 proteolysis. Other detectable chaperone proteins located in the ER lumen remained the same or increased during similar stress activation. This response was specific to ER stress activation and was not observed Fig. 6 The EF-hand Ca 2+ -binding domain regulates FKBP65 stability in the ER. a EF-hand Ca 2+ -binding domains from several proteins, each displaying acidic aspartate (d) and glutamic acid (e) residues at each end of the domain to facilitate Ca 2+ binding at the intersection of two α-helical domains. b An FKBP65-GFP fusion protein was created with an ER retention signal (HEEL), a flexible linker (GSGS), and EE → KK mutations in each EF-hand domain (EF1 and EF2). c Expression of the non-mutant rFKBP65-GFP construct in cultured tsBN7 cells reveals co-localization with ER-RFP consistent with localization to the ER. d Expression of non-mutant rFKBP65-GFP, mEF1, mEF2, and mEF1/mEF2 constructs in tsBN7 fibroblasts. Fractionation of transfected cells reveals the recombinant proteins to display localization within the membrane fraction, consistent with ER localization. Mutation of the EF1 Ca 2+ -binding domain results in diminished rFKBP65-GFP protein within the cell despite cells being transfected with identical amounts of plasmid DNA and equal loading of protein lysates following generalized stress activation, nor was a rapid reduction of FKBP65 observed when protein synthesis was arrested with cyclohexmide. A comparative assessment of gene expression in human cells experiencing ER stress and displaying FKBP65 proteolysis identified a typical UPR-based activation of GRP78/BiP expression, but no change in the expression of FKBP65. This is consistent with the results of Patterson et al. (2005) , who reported that TUN exposure did not alter transcription of FKBP65 in human lung fibroblasts. Cell fractionation experiments revealed ER stress to induce retrotranslocation of FKBP65 from the ER to the cytosol where subsequent proteolysis of FKBP65 is mediated by the proteasome.
Recognizing that ER stress activates Ca 2+ release from the ER lumen, we hypothesized that Ca 2+ binding at EF-hand domains might play an important role in regulating the stability of FKBP65 during times of ER stress. Recombinant FKBP65-GFP was generated, shown to localize to the ER, and to be proteolytically degraded in response to ER stress similar to the native protein. To assess the importance of the EF-hand domains in FKBP65 stability within the ER, point mutations were engineered within the Ca 2+ -binding pockets of EF-hand domains. Mutation of the EF1 domain generated diminished levels of transfected FKBP65 accumulation in the cell compared with cells similarly transfected with the non-mutant recombinant construct. Addition of a proteasome inhibitor facilitated the accumulation of the EF1 mutant proteins to levels near that of the non-mutant recombinant protein. This is consistent with a model that includes diminished Ca 2+ binding at the EF1 domain of FKBP65 as an activator of directing this protein to ERAD-mediated destruction.
FKBP65 participates in the processing of collagen and tropoelastin, two fibrogenic classes of secreted proteins that play a dominant role in the extracellular matrix. Both classes of protein undergo complex processing through the secretory pathway and form fibers following secretion. Collagen proteins are encoded by 42 distinct genes in mammalian cells and are expressed differentially in varied tissues. Within the ER, procollagen monomers are processed by hydroxylation on select proline and lysine residues, glycosylation, and the formation of a procollagen triple helical structure. Following export from the cell, prodomains are removed to complete the production of each collagen molecule, and fibrils begin to self-assemble. Some mutant forms of collagen misfold within the ER and may accumulate in some cases, or are cleared from the cell through the ERAD pathway. Collagen aggregates that form within the ER lumen are handled distinctively, being degraded via export of aggregates from the ER to autophagosomes and autophagy-mediated destruction (Ishida et al. 2009 ). Similarly, an accumulation of tropoelastin within the ER results in the activation of an ERADdependent retrotranslocation and proteolysis (Davis and Mecham 1996) .
Though an extensive analysis of the impact of ER stress signaling upon production of the extracellular matrix components has not been performed, any defect in ER function would be expected to raise the potential for the accumulation of toxic aggregates within the ER lumen. Indeed, the activation of apoptosis in response to accumulated protein aggregates is well documented (Bandopadhyay and de Belleroche 2010; Chiti and Dobson 2006) . Studies of collagen production in diseases of bone formation (chondrodysplasia) revealed ER stress induced within chondrocytes to inhibit collagen secretion as a potential protective mechanism though it generated cartilage pathology consistent with disease (Rajpar et al. 2009 ). In this study, the rapid ERAD-based proteolysis of a key rotamase involved in the processing of fibrogenic proteins could potentially reveal a method of alternative handling or even proteolysis of aggregation-prone, fibrogenic proteins during stress within the ER. We anticipate that an examination of the impact of FKBP65 overexpression or ablation upon collagen or tropoelastin processing, localization, and stability during stress within the ER will clarify this relationship. 
